Literature DB >> 9261781

Impact of peripherally inserted central catheters on phlebitic complications of peripheral intravenous therapy in spinal cord injury patients.

R Paz-Fumagalli1, Y A Miller, B A Russell, M R Crain, R A Beres, M W Mewissen.   

Abstract

We investigated the impact of peripherally inserted central catheter (PICC) placement in spinal cord injury patients at high risk for infusion phlebitis. The rate and etiology of phlebitis was investigated in two phases. During Phase I, peripheral IV cannulae and conventional central venous catheters (CVC) were used. During Phase II, patients identified to be at risk for phlebitis received PICCs. The number of peripheral IVs, CVCs and PICCs was tabulated for both phases of the study. Technical, infectious and thrombotic complications were studied prospectively for PICCs and retrospectively for CVCs. We found the rate of phlebitis was 16.5 percent and 2.4 percent for Phases I and II, respectively (p = 0.0002). Three infections occurred in 38 PICCs and one infection was documented in 13 conventional CVCs. The number of peripheral IVs and conventional CVCs was reduced significantly from Phase I to Phase II. No procedural complications, catheter sepsis or clinically apparent venous thrombosis occurred. In conclusion, PICCs reduced the rate of phlebitis thresholds with a low complication rate and reduced the use of peripheral IVs and conventional CVCs.

Entities:  

Mesh:

Year:  1997        PMID: 9261781     DOI: 10.1080/10790268.1997.11719486

Source DB:  PubMed          Journal:  J Spinal Cord Med        ISSN: 1079-0268            Impact factor:   1.985


  3 in total

1.  Risk factors associated with peripherally inserted central venous catheter-related large vein thrombosis in neurological intensive care patients.

Authors:  Thomas J Wilson; Devin L Brown; William J Meurer; William R Stetler; D Andrew Wilkinson; Jeffrey J Fletcher
Journal:  Intensive Care Med       Date:  2011-11-24       Impact factor: 17.440

2.  Peripherally inserted central venous catheters for autologous blood progenitor cell transplantation in patients with haematological malignancies.

Authors:  C Harter; T Ostendorf; A Bach; G Egerer; H Goldschmidt; A D Ho
Journal:  Support Care Cancer       Date:  2003-09-20       Impact factor: 3.603

3.  A Randomized Trial of Central Venous Catheter Type and Thrombosis in Critically Ill Neurologic Patients.

Authors:  Jeffrey J Fletcher; Thomas J Wilson; Venkatakrishna Rajajee; William R Stetler; Teresa L Jacobs; Kyle M Sheehan; Devin L Brown
Journal:  Neurocrit Care       Date:  2016-08       Impact factor: 3.210

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.